Qumata, a London-based provider of underwriting solutions for life and health insurance, has raised USD 10 million in Series A funding led by MMC Ventures with participation from AdirVentures and existing investors, including TMT Investments. The company’s total funding following this round stands at USD 12.1 million.
The company expects to use the funds to commercialize its product through listed insurers in Europe, Asia-Pacific, the UK, and North America, in addition to expanding its global presence.
Founded in 2017, Qumata (formerly known as HealthyHealth) provides underwriting solutions via an API for life and health insurance companies. The company’s technology collects data such as heart rate, physical activity, and steps from applicants to assess the risk of diagnosis for more than 800 medical conditions, which can then be used by life and health insurers to facilitate underwriting decisions. This approach also reduces the need for applicants to fill out lengthy applications and carry out medical exams.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.